Regeneron Shares Rise More Than 8% Premarket After Q3 Earnings Beat
Regeneron reported stronger-than-expected third-quarter earnings, supported by demand for its eye treatments and higher collaboration revenue from Sanofi. Shares gained more than 8% in premarket trading.
Shares of Regeneron Pharmaceuticals (REGN) gained more than 8% in premarket trading on Friday, after the biotechnology firm reported stronger-than-expected third-quarter earnings, driven by growing demand for its eye treatments and higher collaboration revenue from Sanofi.If the levels hold after t…